HLVX Projected Dividend Yield
HilleVax Inc ( NASDAQ : HLVX )HilleVax, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing vaccines. Co.'s program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Norovirus is the most common cause of viral AGE worldwide and is characterized by symptoms, including diarrhea, vomiting, abdominal pain, nausea, and, sometimes, fever that may lead to clinically significant dehydration. 21 YEAR PERFORMANCE RESULTS |
HLVX Dividend History Detail HLVX Dividend News HLVX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |